Bangkok Lab And Cosmetic Past Earnings Performance
Past criteria checks 3/6
Bangkok Lab And Cosmetic has been growing earnings at an average annual rate of 45.4%, while the Pharmaceuticals industry saw earnings growing at 11.2% annually. Revenues have been growing at an average rate of 9.7% per year. Bangkok Lab And Cosmetic's return on equity is 9.5%, and it has net margins of 10.3%.
Key information
45.4%
Earnings growth rate
36.8%
EPS growth rate
| Pharmaceuticals Industry Growth | 12.4% |
| Revenue growth rate | 9.7% |
| Return on equity | 9.5% |
| Net Margin | 10.3% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Bangkok Lab And Cosmetic makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 1,417 | 145 | 602 | 0 |
| 30 Sep 23 | 1,421 | 137 | 585 | 0 |
| 30 Jun 23 | 1,386 | 141 | 574 | 0 |
| 31 Mar 23 | 1,355 | 127 | 555 | 0 |
| 31 Dec 22 | 1,242 | 126 | 532 | 0 |
| 31 Dec 21 | 1,095 | 52 | 482 | 0 |
| 31 Dec 20 | 1,107 | 12 | 523 | 0 |
Quality Earnings: BLC has high quality earnings.
Growing Profit Margin: BLC's current net profit margins (10.3%) are higher than last year (10.1%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if BLC's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Insufficient data to compare BLC's past year earnings growth to its 5-year average.
Earnings vs Industry: BLC earnings growth over the past year (15.6%) exceeded the Pharmaceuticals industry 6.2%.
Return on Equity
High ROE: BLC's Return on Equity (9.5%) is considered low.